Clover Biopharmaceuticals, Ltd. Transaction

Listed Equity Investment New Security Issue in China, Asia

Transaction Details

Name:Clover Biopharmaceuticals, Ltd.
Amount:Available on swfi.com
Announced At:10/01/2021
Closed At:10/01/2021
RegionAsia
Country:China
Type:New Security Issue
Security Type:Ordinary Shares
Investment Type:Listed Equity
SectorHealthcare
Industry:Biotechnology
Summary:Available

Buyers

Entity 1
Sovereign Wealth Fund in Singapore		Stake
Available on swfi.com